Trevor D. Wolterink

Trevor D. Wolterink

Auto-generated profile, based on publicly available information

Trevor D. Wolterink

Medical University of South Carolina, Department of Orthopaedics and Physical Medicine, Charleston, South Carolina, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2026 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
MNMitchell H. Negus
Mitchell H. Negus
MGMatthew E. Guareschi
Matthew E. Guareschi
LWLauren Wohlrab
Lauren Wohlrab
TWTrevor Wolterink
Trevor Wolterink
RRRobert J. Reis
Robert J. Reis
JEJosef K. Eichinger
Josef K. Eichinger
Background: Ulnar collateral ligament (UCL) reconstruction has historically been considered the gold standard treatment for severe UCL tears. With the advent of suture-spanning repair techniques, some studies suggest that UCL repair is being performed with increasing frequency. This study provides a large analysis of UCL reconstruction versus repair trends in the United States following the introduction of suture-spanning repair techniques. Purpose: To compare the prevalence and complication rates of UCL reconstruction versus repair over a 5-year span following the introduction of suture spanning repair techniques. We also sought to determine if there was an age-related preference for reconstruction versus repair and whether the addition of an ulnar nerve transposition (UNT) affected short-term complication rates. Study Design: Cohort study; Level of evidence, 3. Methods: Using the Merative MarketScan research databases, which contain deidentified patient national claims information, we retrospectively identified patients aged 14 to 30 years who underwent UCL reconstruction or repair between 2016 and 2021, with or without UNT. Patients with a fracture diagnosis at the time of surgery were excluded. Demographic information including age, sex, and geographic region was collected. The number of patients who experienced infection, ulnar neuropathy, device-related complications, and unspecified complications were obtained for each procedure. Results: A total of 1191 reconstruction patients and 696 repair patients were identified. 36.8% of patients who underwent either reconstruction or repair had a concomitant UNT. UCL reconstruction patients were approximately 3 years older than repair patients on average ( P < .001). Male patients accounted for 89.5% of reconstruction patients and 77.7% of repair patients. From 2016 to 2021, the number of reconstructions declined 32.0% and the number of repairs increased 81.6%. There were no differences in the rate of infection ( P = .36) and ulnar neuropathy ( P = .73) between reconstruction and repair. The overall risk of developing any complication was higher for repair patients (1.58%) than reconstruction patients (0.67%); however, this difference was not significant ( P = .09). Conclusion: Between 2016 and 2021, following the introduction of suture spanning UCL repair techniques, the number of UCL repairs increased and the number of reconstructions decreased. There was no difference in complication rates between UCL repair and UCL reconstruction and the rate of complication for either surgery remains low.

8 June 2026 in Arthroscopy, Sports Medicine, and Rehabilitation
Verified
Journal Article
Open access
PDF file
TWTrevor D. Wolterink
Trevor D. Wolterink
GCGermain Craddock
Germain Craddock
JCJoshua P. Castle
Joshua P. Castle
MGMichael A. Gaudiani
Michael A. Gaudiani
COChimdindu Obinero
Chimdindu Obinero
SMStephanie J. Muh
Stephanie J. Muh
Purpose: To evaluate the effect of perioperative dexamethasone on patient‐reported pain, functional outcomes, and minimal clinically important difference (MCID) achievement following arthroscopic rotator cuff repair. Methods: Patients who underwent rotator cuff repair between 2013 and 2023 were identified and divided into groups. Those who received peri operative dexamethasone were compared with controls. Outcomes included visual analog scale (VAS) pain, patient‐reported outcomes measurement information system (PROMIS) upper extremity, PROMIS pain interference, and MCID. Multivariate logistic and linear regression models adjusted for age, sex, body mass index, diabetes, race/ethnicity, smoking, and preoperative opioid use. Subgroup analyses were performed by tear size. Results: A total of 309 patients was included (187 dexamethasone and 122 control). Dexamethasone administration was associated with improved functional recovery and sustained pain reduction. PROMIS upper extremity and PROMIS pain interference scores favored Dexamethasone at 6 weeks, 3 months, and 6 months (all P < .01). VAS pain was significantly lower at 12 months (1.9 ± 2.9 vs 3.1 ± 3.5, P = .003) and 24 months (1.0 ± 2.5 vs 1.8 ± 3.1, P = .035). Only 37% of patients completed a 2‐year follow‐up, limiting the strength of these long‐term comparisons. In small/medium tears, MCID achievement for VAS was greater at 6 weeks (31% vs 21%, P = .041) and 3 months (34% vs 21%, P = .012). Logistic regression confirmed dexamethasone as an independent predictor of early MCID (OR 1.67, 95% CI 1.02‐2.73, P = .041). Large/massive tears showed transient VAS improvement without MCID benefit. Opioid consumption did not differ between groups (all P > .12). Dexamethasone reduced ondansetron use in large/massive tears at 0‐4 hour (β = −0.34, P = .04) and in small/medium tears at 4‐8 hour (β = −0.19, P = .04), with no differences for other antiemetics. Complication rates were similar (11.2% vs 4.9%, P = .055). Conclusions: Perioperative intravenous dexamethasone is a safe adjunct to arthroscopic rotator cuff repair, supporting early antiemetic benefits, durable pain relief, and selective improvements in patient‐reported outcomes. Benefits appear most pronounced in small/medium tears at early follow‐up and large/massive tears at later stages, suggesting tear size‐specific response. Level of Evidence: Level III, retrospective comparative study.

20 March 2026 in Journal of Shoulder and Elbow Arthroplasty
Verified
Journal Article
Open access
JRJared J. Reid
Jared J. Reid
TWTrevor D. Wolterink
Trevor D. Wolterink
RRRobert J. Reis
Robert J. Reis
BRBrandon L. Rogalski
Brandon L. Rogalski
JEJosef K. Eichinger
Josef K. Eichinger
RFRichard J. Friedman
Richard J. Friedman
Socioeconomic status (SES), as measured by the Area Deprivation Index (ADI), is associated with differences in pre-operative status and post-operative outcomes in patients undergoing total shoulder arthroplasty (TSA). The effect of SES on TSA outcomes remains unclear, as studies thus far report mixed findings overall. The purpose of this study is to determine the association between SES at the neighborhood level, using ADI scores, and patient-reported outcome measures (PROMs) following TSA. A retrospective review of a prospectively collected single-institution database was performed to identify patients who underwent primary TSA (Advita Ortho) with a minimum 2-year follow-up. Patient addresses were collected and converted to ADI scores. Patients were divided into quartiles of ADI, and the most deprived (ADIHigh) and least deprived (ADILow) quartiles were compared. Pre- and post-operative range of motion (ROM) and PROM, along with complication and revision rates at the last follow-up, were obtained. For ROM, visual analog scale pain, global function score and American Shoulder and Elbow Surgeons scores, the Minimal Clinically Important Difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) were defined by previously established threshold values. Multivariable logistic regression models were estimated to characterize the association of the ADI with MCID, SCB, and PASS attainment along PROM domains. A total of 599 procedures with a minimum of 2-year follow-up and ADI score were grouped into distinct quartiles for analysis, and the ADILow (n = 150, ADI 0-25) and ADIHigh (n = 150, ADI 67-100) groups were compared. ADIHigh demonstrated inferior pre-operative ROM and PROM compared to ADILow. These differences decreased post-operatively, remaining statistically but not clinically significant for visual analog scale pain, global shoulder function, and American Shoulder and Elbow Surgeons scores. Each group achieved MCID, SCB, and PASS at similar rates. ADI was not a significant predictor of achieving MCID, SCB, and PASS thresholds. SES impacts pre-operative disease severity and absolute post-operative outcomes after TSA but does not significantly limit the capacity for clinically meaningful improvement. Disadvantaged patients derive similarly substantial benefit from surgery compared to those from higher SES backgrounds.